SpaceX (Nasdaq: SPCX) began trading on June 12, 2026, in what is, by total proceeds, the largest initial public offering on record. If you held SpaceX privately (directly, through employee equity, or as a limited partner in a venture fund) the event is less an ending than a beginning. An illiquid private holding has just become a concentrated, richly valued, and, for now, restricted position in a public company.
The months surrounding an IPO and its lock-up are among the most consequential, and most time-sensitive, planning windows a shareholder will ever face. The strategies below are the ones sophisticated holders use to manage concentration risk, improve tax efficiency, and preserve wealth across generations. None of this is a recommendation; the right combination depends entirely on your facts. But the window is real, and it is open now.
Start with the calendar, not the strategy
The most important document for any SpaceX shareholder today is the lock-up language in the company’s registration statement. It governs when you can actually transact, and nearly every decision that follows is timed against it.
Most IPOs use a flat 180-day lock-up. SpaceX did something more elaborate. Its S-1 sets out a staggered, partly performance-based early-release schedule that lets eligible holders sell in tranches well before the six-month mark:
- A first tranche of up to 20% of eligible locked-up shares frees up after SpaceX reports its first quarter of results as a public company, the quarter ending June 30, with that earnings release expected sometime between mid-July and September.
- An additional 10% can release early if the Class A shares trade at least 30% above the IPO price on at least five of ten consecutive trading days ahead of that first earnings report. This is a performance trigger that rewards a strong debut.
- Five further time-based tranches of roughly 7% each unlock at 70, 90, 105, 120, and 135 days after the offering.
- A larger 28% tranche releases after the second public earnings report, the quarter ending September 30, expected mid-October to December.
- Whatever remains comes off restriction at the 180-day mark, around mid-December.
Two carve-outs matter. First, Elon Musk is deliberately excluded from the accelerated schedule; he along with certain unnamed “significant investors” agreed to a longer hold, reported at a minimum of 366 days. Second, no existing holders sold into the offering itself; only the company issued new shares. The staggered design is widely read as a way to expand the public float quickly enough to qualify for fast-track Nasdaq-100 inclusion.
Here is the practical point. Which bucket you fall into: 1. the standard staggered release, 2. the full 180-day restriction, or 3. the 366-day “significant investor” lock, depends on your specific agreement and category. Before you build any plan around a date, confirm which schedule actually applies to your shares.
And one feature of lock-ups that almost no one reads closely: lock-up agreements of this kind customarily permit certain transfers even while outright sales are barred. These typically include bona fide gifts and transfers to trusts and estate-planning vehicles, provided the recipient agrees to be bound by the same restrictions. In other words, the clock on selling and the clock on gifting are not the same clock.
Know how you actually hold the shares
Before any strategy can be evaluated, one structural question controls everything: do you hold shares in your own name, or an interest in a fund that holds them for you? Investors who came in through a venture vehicle typically hold a limited-partnership interest, not shares directly. In that arrangement, the general partner, not you, controls timing while the position sits inside the fund.
The common path is an in-kind distribution: after the IPO and the relevant lock-up releases, the fund distributes the underlying SPCX shares to its partners rather than selling and distributing cash. Three features are worth understanding in advance:
- Carryover basis and a tacked holding period. You generally inherit the fund’s cost basis, and the fund’s holding period tacks onto yours so distributed shares are usually already long-term in your hands.
- The marketable-securities wrinkle. Partnership distributions of marketable securities can, by default, be treated as cash and trigger gain. A widely relied-upon exception applies to securities that were not marketable when the fund acquired them, which is generally the case for venture-stage SpaceX stock, so these distributions are frequently tax-deferred. The rule is fact-specific; confirm it with the fund’s tax team and your CPA.
- The lock-up follows the shares. Shares distributed to you generally remain subject to the same lock-up and resale restrictions that bound the fund. Receiving them does not by itself make them freely salable.
The interval between distribution and free salability is not dead time. In fact, it is often the ideal window for hedging, charitable, and wealth-transfer planning, several of which can be executed even while selling is restricted.
The QSBS question and why it doesn’t apply
The first tax provision any advisor screens for is Section 1202, which can exclude some or all of the gain on “qualified small business stock.” The 2025 tax law made it more generous for stock acquired after July 4, 2025: a tiered exclusion (50% at three years, 75% at four, 100% at five), a per-issuer cap raised to $15 million, and a higher $75 million gross-asset ceiling.
The conclusion, though: for shares tied to a venture-era SpaceX investment, QSBS almost certainly does not apply. The exclusion is available only if the company’s gross assets were at or below the statutory ceiling when the stock was issued, and SpaceX exceeded that threshold many years before most outside capital came in. Ruling out the QSBS benefit correctly is part of the process for most shareholders here. However, if you hold a genuinely early, separately acquired tranche, it is worth a specific look.
Managing concentration and liquidity
A single position this large, trading at an extraordinary multiple of revenue and carrying real execution risk, is the textbook definition of concentration. Several tools address that risk without forcing an immediate, fully taxable sale.
Exchange (“swap”) funds
Now that SPCX is public, eligible shares can potentially be contributed to a diversified partnership in exchange for a pro-rata interest in a broad basket. This allows you to defer the built-in gain while replacing single-stock risk with diversification. The trade-offs are a multi-year holding commitment (commonly around seven years) and the fund’s structural requirements.
Protective collars and prepaid variable forwards
A collar (buying a put, selling a call) brackets the position’s value against a sharp decline, especially relevant for a freshly public, volatile stock. A prepaid variable forward goes further, advancing a large share of the value in cash today while deferring the sale and the gain. Both must be structured to avoid “constructive sale” treatment and are typically deployed once lock-up restrictions permit.
Securities-based lending
Once the shares are unrestricted, borrowing against them can supply liquidity without selling. Lock-ups generally prohibit pledging during the restricted period, so this is a post-release tool and one that demands discipline around loan-to-value when the collateral is a single, volatile name.
Programmatic selling
If you or the distributing fund is treated as an affiliate, a pre-established Rule 10b5-1 plan allows disciplined, scheduled diversification on a fixed timetable. Mapped onto the staggered release dates above, a rules-based selldown also removes emotion from the decision to trim a position you believe in.
Offsetting and deferring the tax of diversifying
Most of the tools above eventually require realizing gain and a low-basis position means a meaningful tax bill on the way out. These strategies soften that tax impact.
Tax-aware long/short loss harvesting
A long-only “direct indexing” account harvests losses by selling index constituents that dip, but the opportunities shrink as the market rises. A tax-aware long/short strategy maintains both a long and a short book, so dispersion on one side or the other produces harvestable losses year after year, precisely what is needed to absorb the gains you realize as you trim SPCX. Run alongside a staged sell-down and it can let you exit a concentrated position over time at a fraction of the headline tax cost.
Three considerations when implementing a L/S TLH strategy: 1. the technique defers and re-characterizes tax rather than eliminating it (harvesting lowers the basis of replacement holdings, with the gain resurfacing later); 2. wash-sale discipline is the manager’s job; and 3. strategy costs and market risk must clear the after-tax benefit to be worth it.
A direct-indexing completion overlay
A lighter-touch option: build the diversified portfolio as a completion account that deliberately underweights SPCX’s sectors and factor exposures, neutralizing the concentration at the total-portfolio level even before you sell, while harvesting along the way.
Qualified Opportunity Funds
For gains you do realize, a Qualified Opportunity Fund (QOF) can defer them. The original program reaches its deferral cliff at the end of 2026, but the 2025 law made Opportunity Zones permanent as a renewed program beginning January 1, 2027, with a rolling five-year deferral, a 10% basis step-up at five years (30% for qualified rural funds), and the long-standing exclusion of the fund’s own appreciation after a ten-year hold preserved. A QOF requires committing capital to illiquid opportunity-zone assets, so it suits only the portion of a portfolio that can accept that profile.
Charitable and income-tax efficiency
Highly appreciated, low-basis stock is the ideal asset to give. Contributing shares rather than cash sidesteps the embedded capital-gains tax and, for itemizers, generates a fair-market-value deduction.
Charitable remainder trust (CRT)
The standout structure for a large, low-basis position. You contribute shares; the trust (itself tax-exempt) can sell them without an immediate capital-gains hit and reinvest into a diversified portfolio. You receive an income stream for life or a term of years, take a partial deduction up front, and direct the remainder to charity. In one move, the CRT addresses concentration, taxes, income, and philanthropy.
A common refinement pairs the CRT with an irrevocable life insurance trust (ILIT): part of the income stream, or the up-front tax savings, funds life insurance held in the ILIT, replacing the donated value for your heirs free of income and estate tax. The combination lets you be philanthropic without disinheriting the next generation, often the very objection that stops people from using a CRT at all.
Donor-advised fund (DAF)
A simpler companion: donate appreciated shares, avoid the capital-gains tax, claim the deduction in the contribution year, and recommend grants over time. Well suited to a one-time liquidity event where you want the deduction now and flexibility on the giving later.
Wealth transfer and why the lock-up window is the opportunity
The 2025 law also made the federal estate and gift tax framework unusually favorable and, for the first time in years, stable: a lifetime exemption of $15 million per person ($30 million per married couple) in 2026, indexed and aligned with the generation-skipping transfer exemption, and made permanent rather than scheduled to sunset.
The key is timing. Techniques that transfer future appreciation out of your estate work best when an asset is volatile and before it climbs further, often the with a newly public, richly valued stock.
The clock on selling and the clock on gifting are not the same clock. Because lock-ups customarily permit transfers to trusts and charitable entities, the estate-planning window often opens before you can sell a single share.
Grantor retained annuity trusts (GRATs)
A GRAT transfers appreciation above an IRS-set hurdle rate to your heirs at little or no gift-tax cost. Because SPCX will likely be a volatile holding, a series of short, rolling GRATs can capture upside spikes while limiting the downside of any single trust.
Sale to an intentionally defective grantor trust (IDGT)
Selling shares to a grantor trust for a promissory note freezes the value in your estate at today’s price while shifting future growth outside it, with no immediate income tax on the sale. It pairs naturally with using part of the lifetime exemption to seed the trust.
Key considerations
Much of the classic pre-IPO playbook including valuation discounts for lack of marketability or gifting at suppressed private valuations closed with the IPO. Publicly traded, liquid shares no longer support those discounts. Second, gifting low-basis shares during life forfeits the basis step-up that would otherwise occur at death, so transfer planning must always be weighed against simply holding for that step-up. The right answer balances estate-tax exposure against income-tax basis.
A note for California residents
For a California-based holder, the embedded gain is not only a federal matter. California taxes capital gains as ordinary income at rates reaching roughly 13.3%, so the state’s share of a large SPCX gain can be substantial on its own. A natural instinct is to move the gain beyond California’s reach using an incomplete-gift non-grantor trust in a no-tax state such as Nevada or Delaware (a “NING” or “DING”). That door, however, is effectively closed: under legislation enacted in 2023, California treats these trusts as grantor trusts for state income-tax purposes, taxing the California-resident grantor as though the trust did not exist.
The levers that remain are more straightforward: a genuine change of residency before a sale; completed-gift non-grantor trusts (which use lifetime exemption and also remove the asset from your estate); and the charitable remainder trust, whose tax-exempt sale sidesteps the state-level tax on the gain as well as the federal. We mention the NING specifically because it is still actively marketed by some advisors even though it no longer works for California residents.
The real opportunity is sequencing
No single one of these strategies is right for everyone, and most are most effective in combination and in sequence, mapped against the specific lock-up dates that apply to your shares. The value of an adviser here is not necessarily in uncovering the strategy; it is acting as the quarterback: coordinating your CPA and estate attorney, building the calendar, and fitting a plan to your liquidity needs, your family goals, and your tolerance for keeping skin in a remarkable company.
If you are holding SpaceX shares, directly or through a fund, and want to discuss how to optimize your wealth and tax strategy, contact a Carrara advisor today.
_________________________________________________________
IMPORTANT DISCLOSURES
This article is provided for general educational and informational purposes only and is current as of June 2026. It is based on tax and securities laws then in effect, including provisions of the One Big Beautiful Bill Act of 2025, and on publicly available information about the SpaceX initial public offering, including its registration statement on Form S-1 and related public reporting; those laws and facts are subject to change and to differing interpretation. Nothing herein constitutes investment, tax, legal, or accounting advice, a recommendation, or an offer or solicitation to buy or sell any security, including SPCX. References to SpaceX are illustrative and do not constitute a recommendation regarding that security. The strategies described are general in nature, may not be suitable for any particular investor, often involve significant complexity, cost, illiquidity, and risk (including the risk of loss) and depend on individual circumstances this article does not address. Many require qualified tax counsel and estate-planning attorneys. You should consult your own CPA, attorney, and financial adviser before acting on any idea discussed here. Registration as an investment adviser does not imply any particular level of skill or training. Additional information about Carrara Capital, LLC, including its Form ADV, is available through the Investment Adviser Public Disclosure system at adviserinfo.sec.gov.